|
SingulairDrug - Singulair The trade name of the product as shown on the labeling.
Dosage -
GRANULE; ORAL
Active Ingredient(s) -
Montelukast Sodium
Strength -
EQ 4MG BASE/PACKET
Applicant -
MERCK
New Drug Application (NDA) Number -
021409
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Jul 26, 2002
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Merck Research Laboratories Div Merck Co Inc
Singulair
Mometasone Furoate 0.1% Ointment; Topical
Mometasone Furoate 0.1% Ointment; Topical Mometasone Furoate 0.1% Ointment; Topical Mometasone Furoate 0.1% Ointment; Topical Asmanex Twisthaler 0.22mg/inh Powder; Inhalation Nasonex Eq 0.05mg Base/spray Spray, Metered; Nasal Benoquin 20% Cream; Topical Moctanin 100% Liquid; Perfusion, Biliary Singulair Eq 4mg Base/packet Granule; Oral Elocon 0.1% Ointment; Topical NewDrugInformation |